Vaccine Covivac The Coviv-19 Room of Vietnam is preparing to switch to phase 2 clinical trials, expected at the end of July, early August in Thai Binh. Covivac Vaccine Testing at Hanoi Medical University. Photo: Le Ruong Japanese Progress Trials Clinical Vaccine Covivac Covivac Room Covid-19 of Vaccine Institute and Medical Biology (IVAC), Assoc. Prof. Dr
. Vu Dinh Thinh, Director of Clinical Trial Center, Institute of Hygiene and Epidemiology The central central said: "The research team is waiting for the results of data analysis of the Safety of Covivac Vaccine from Thailand and the immune test results from Canada to deploy the mid-term reception". The Safety analysis of Vaccine Covivac will be available on July 9, and the results of immune birth will be available on July 19. Later, the team will submit to the mid-term report to the Ethics Council and the Ministry of Health to consider and decide to continue to continue the stage of the 2
au 6 visits for the first treacher volunteers In phase 1, the research team has collected basic data to analyze the safety of the vaccine. The team asked a clinical trial monitoring organization and a unit in Thailand to independently inspected and objectively about the quality of data, analyzing the ratio of adverse events in place, as well as : Swelling, redness, pain after injection ...; Assessing the severity, mild levels of side effects and unexpected adverse events. According to Vu Dinh Quy, the research team is completing the preparation; Trying at the end of July or early August will begin injecting phase 2.Theo plan, phase 2 will be implemented in Vu Thu district, Thai Binh province. The number of volunteers participating in this period is about 300 volunteers; The implementation will try to complete within 3-4 months. It is expected that around October 2021 there will be preliminary results of phase 2 to forward to stage 3.Giai Section 1 Vaccine Covivac clinical trial starts from March 2021 at Hanoi Medical University Hospital , there were 120 volunteers to participate in test injections, divided into 5 groups including: 20 placebo injectors and 100 vaccines with doses: 1 mcg, 3 mcg and 10 mcg; Along with a dose-level vaccine test group 1 MCG has a substance supplement
The testing purpose of phase 1 is to assess the safety, immunity and disadvantage events when injecting vaccines according to different doses . . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
